Structure via PubChem · Public domain (PubChem)
clomifene
Sign in to saveAlso known as Androxal®, Clomifenum, 2-(p-(β-chloro-α-phenylstyryl)phenoxy)triethylamine, Clomiphene, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine, Clomifeno, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine
Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome. It is taken by mouth.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 460044105
- Drug.image
- Clomiphene.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.class
- Selective estrogen receptor modulator; Progonadotropin
- Drug.ATC_prefix
- G03
- Drug.ATC_suffix
- GB02
- Drug.legal_AU
- S4
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
- Drug.bioavailability
- High (>90%)
- Drug.metabolism
- Liver CYP2D6 (with enterohepatic circulation)
- Drug.metabolites
- 4-Hydroxyclomiphene (4-OH-CLO), 4-Hydroxy-N-desethylclomiphene (4-OH-DE-CLO)
- Drug.elimination_half life
- 4–7 days active metabolites: 4-OH-CLO : 13–34 hrs 4-OH-DE-CLO : 15–37 hrs
- Drug.excretion
- Mainly feces, some in urine
- Drug.CAS_number
- 911-45-5
via Wikipedia infobox
Chemical data
- Formula
- C26H28ClNO
- Molecular weight
- 406 g/mol
- IUPAC name
- 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine
- SMILES
- CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3
- InChIKey
- GKIRPKYJQBWNGO-UHFFFAOYSA-N
- XLogP
- 7.2
- Polar surface area
- 12.5 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Research
7,645 papers- Multiple pregnancy rate in patients undergoing treatment with clomifene citrate for WHO group II ovulatory disorders: a systematic review.Human fertility (Cambridge, England) · 2022
- Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.Current opinion in obstetrics & gynecology · 2009
- Clomifene and Assisted Reproductive Technology in Humans Are Associated with Sex-Specific Offspring Epigenetic Alterations in Imprinted Control Regions.International journal of molecular sciences · 2022
- Ovulation induction with clomifene: a primary care perspective.The journal of family planning and reproductive health care · 2012
- The influence of ethnicity on outcomes of ovulation induction with clomifene citrate in women with PCOS.Reproductive biomedicine online · 2022
via PubMed
Wikidata facts
- Mass
- 405.186
Show 6 more facts
- defined daily dose
- 9
- chemical formula
- C₂₆H₂₈ClNO
- Commons category
- Clomifene
- World Health Organisation international non-proprietary name
- clomifene
- canonical SMILES
- CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3
- stylized name
- clomiPHENE
Sources (8)
via Wikidata · CC0
~18 min read
Article
19 sectionsContents
- Medical uses
- Reproductive medicine
- Testosterone replacement therapy
- Gynecomastia
- Prohibited use in sports
- Contraindications
- Side effects
- Cancer risk
- Pharmacology
- Pharmacodynamics
- Selective estrogen receptor modulator activity
- Other activities
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Brand names
- Research
- References
Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome. It is taken by mouth.
Common side effects include pelvic pain and hot flashes. Other side effects can include changes in vision, vomiting, trouble sleeping, ovarian cancer, and seizures. It is not recommended in people with liver disease or abnormal vaginal bleeding of unknown cause or who are pregnant. Clomifene is in the selective estrogen receptor modulator (SERM) family of medication and is a nonsteroidal medication. It works by causing the release of GnRH by the hypothalamus, and subsequently gonadotropin from the anterior pituitary.